Literature DB >> 8539407

Pulmonary angiography performed with iopamidol: complications in 1,434 patients.

E R Hudson1, T P Smith, V G McDermott, G E Newman, P V Suhocki, C S Payne, D J Stackhouse.   

Abstract

PURPOSE: To evaluate the safety of pulmonary angiography performed with iopamidol compared with pulmonary angiography performed with ionic contrast media.
MATERIALS AND METHODS: The data in 1,434 patients who underwent pulmonary angiography with iopamidol 76% were retrospectively reviewed. Complications that occurred within 48 hours were identified with review of hospital charts and/or computer records.
RESULTS: Pulmonary arterial hypertension was present in 402 patients and was severe in 99. Pulmonary embolus was diagnosed in 357 patients (24.9%). Major complications occurred in four patients (0.3%). Respiratory insufficiency occurred in two of these patients. Catheterization was not completed in two patients due to catheter-induced cardiac arrhythmia that was refractory to treatment. No procedure-related deaths occurred. During the periprocedural period, eight patients required intubation and 10 patients died; all patients previously were critically ill.
CONCLUSION: Pulmonary angiography is a safe procedure, and the margin of safety is enhanced by the use of iopamidol.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8539407     DOI: 10.1148/radiology.198.1.8539407

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

Review 1.  Pulmonary thromboembolism in children.

Authors:  Paul S Babyn; Harpal K Gahunia; Patricia Massicotte
Journal:  Pediatr Radiol       Date:  2005-01-06

Review 2.  The challenges of managing cancer related venous thromboembolism in the palliative care setting.

Authors:  S Noble
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

3.  Catheter-Induced Pulmonary Artery Dissection and Contrast Extravasation During Pulmonary Angiography.

Authors:  Daniel T Ginat; Lawrence Sahler
Journal:  Radiol Case Rep       Date:  2016-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.